Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area

Autor: James J. Davis, Ghazaleh Eskandari, Daniel R. Boutz, Layne Pruitt, James M. Musser, Maulik Shukla, Jason S. McLellan, Chia Wei Chou, Marcus Nguyen, Jimmy Gollihar, J. Hunter Long, Muthiah Kumaraswami, Jule Goike, David W. Bernard, Sishir Subedi, Heather Hendrickson, S. Wesley Long, Kamyab Javanmardi, Prasanti Yerramilli, Matthew Ojeda Saavedra, Randall J. Olsen, Hung-Che Kuo, Ilya J. Finkelstein, Paul A. Christensen, Hoang A. T. Nguyen
Rok vydání: 2020
Předmět:
Models
Molecular

viruses
Viral Nonstructural Proteins
medicine.disease_cause
Genome
Machine Learning
Clinical Science and Epidemiology
COVID-19 Testing
0302 clinical medicine
Sequence Analysis
Protein

Genotype
Pandemic
030212 general & internal medicine
skin and connective tissue diseases
Phylogeny
Coronavirus
Infectivity
education.field_of_study
0303 health sciences
Coronavirus RNA-Dependent RNA Polymerase
Transmission (medicine)
virus diseases
Texas
QR1-502
3. Good health
genome sequencing
Molecular Diagnostic Techniques
Spike Glycoprotein
Coronavirus

Coronavirus Infections
Research Article
Pneumonia
Viral

Population
Virulence
Genome
Viral

Biology
Microbiology
Article
Virus
Betacoronavirus
03 medical and health sciences
Immune system
Virology
evolution
medicine
Humans
Amino Acid Sequence
education
Pandemics
COVID-19 disease
030304 developmental biology
Base Sequence
molecular population genomics
Clinical Laboratory Techniques
SARS-CoV-2
fungi
COVID-19
RNA-Dependent RNA Polymerase
Antibodies
Neutralizing

body regions
Amino Acid Substitution
Zdroj: mBio
medRxiv
article-version (status) pre
article-version (number) 3
mBio, Vol 11, Iss 6 (2020)
Popis: There is concern about second and subsequent waves of COVID-19 caused by the SARS-CoV-2 coronavirus occurring in communities globally that had an initial disease wave. Metropolitan Houston, TX, with a population of 7 million, is experiencing a massive second disease wave that began in late May 2020. To understand SARS-CoV-2 molecular population genomic architecture and evolution and the relationship between virus genotypes and patient features, we sequenced the genomes of 5,085 SARS-CoV-2 strains from these two waves. Our report provides the first molecular characterization of SARS-CoV-2 strains causing two distinct COVID-19 disease waves.
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in metropolitan Houston, TX, an ethnically diverse region with 7 million residents. The genomes were from viruses recovered in the earliest recognized phase of the pandemic in Houston and from viruses recovered in an ongoing massive second wave of infections. The virus was originally introduced into Houston many times independently. Virtually all strains in the second wave have a Gly614 amino acid replacement in the spike protein, a polymorphism that has been linked to increased transmission and infectivity. Patients infected with the Gly614 variant strains had significantly higher virus loads in the nasopharynx on initial diagnosis. We found little evidence of a significant relationship between virus genotype and altered virulence, stressing the linkage between disease severity, underlying medical conditions, and host genetics. Some regions of the spike protein—the primary target of global vaccine efforts—are replete with amino acid replacements, perhaps indicating the action of selection. We exploited the genomic data to generate defined single amino acid replacements in the receptor binding domain of spike protein that, importantly, produced decreased recognition by the neutralizing monoclonal antibody CR3022. Our report represents the first analysis of the molecular architecture of SARS-CoV-2 in two infection waves in a major metropolitan region. The findings will help us to understand the origin, composition, and trajectory of future infection waves and the potential effect of the host immune response and therapeutic maneuvers on SARS-CoV-2 evolution.
Databáze: OpenAIRE